Our research has established the pivotal role of SERPINA3 in diabetes-related cognitive impairment, suggesting that the modulation of this gene or its associated signalling pathways may provide novel approaches for DCI prevention, diagnosis, and treatment. This evidence concerns the gene SERPINA3 and Cognitive impairment.